|
|
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 3 |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Synexa Life Sciences BV
0 Patents (Medical) associated with Synexa Life Sciences BV
100 Deals associated with Synexa Life Sciences BV
100 Translational Medicine associated with Synexa Life Sciences BV